IDO1 and neoplasm: IDO expression in the tumor environment (TME) has been linked to the induction of multiple tolerogenic immune phenotypes, including the inhibition of effector T cell activation, enhanced infiltration of myeloid-derived suppressor cells (MDSCs), B cell dysfunction and promotion of tumor angiogenesis (16, 17).